Festival of Biologics 2024 | Terrapinn | 14 October 2024 | Hall 1, Messe Basel, Messepl. 10, 4005 Basel, Switzerland

The start to finish of biologic drug development from discovery through to market access across 3 days and 13 tracks. 150 leading solution providers to meet your needs across discovery, development, manufacturing, fill finish and market access.

Content themes:
• Disease Areas
• Therapies
• Discovery
• Development
• Clinical Trials Operations
• Manufacturing
• Fill & Finish and Logistics
• Finance and Investment
• Commercialisation and Market Access
• Diagnostics

2024 Speakers

Esam Abualrous
Principal Scientist, Schrödinger

Richard Adair
Virology Senior Manager, SGS

Tim Aitman
Director of Centre for Genomic and Experimental Medicine, University of Edinburgh

Amer-Denis Akkad
Head of Transactional Science, Absci

Felipe Albrecht
Principal Scientist, pRED D&A Governance & Strategy, Roche

Ana Filipa Alexandre
Senior Director, Pipeline Head for Neuroscience, Teva Pharmaceuticals

Juan Carlos Almagro
R&D Director, UDIBI-National Polytechnique Institute

Luis Alvarez-Vallina
H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO)

David Auslander
Principal Scientist, Novartis

Sameer Awsare
Associate Executive Director, The Permanente Medical Group Inc

Ronald Backer
Senior Scientist of Field Application, Luminex Corporation

Baptiste Balbuena
Application Engineer Downstream, Merck Group

Alain Beck
Senior Director, Centre d'Immunologie Pierre Fabre

Philip Beer
Chief Scientific Officer, Step Pharma

Stephen Beers
Professor of Immunology and Immunotherapy, University of Southampton

Jean-François Bellec
Biologics Market Development Manager, Bio-Techne

Nicola Beltraminelli
Chief Development Officer, Head of RED, INNATE PHARMA

Ralph Beneke
Market Specialist for Molecular Biology Research, Agilent Technologies

Romain Bertrand
Director, ADC Chemistry, Araris Biotech AG

Martin Bertschinger
Deputy Cell Sciences Director, Ichnos Glenmark Innovation

Oren Beske
Amalgamator of Business and Biology, ATUM BIO

Thierry Besson
Senior Scientist II, Novartis

Gina Bicknell
Partner, Pinsent Masons

Simone Bido
Researcher, IRCCS Ospedale San Raffaele

Oliwia Bochenska
Analytical Expert at Development and Contract Testing Department, Selvita

Igor Bogdanoski
Feasibility Manager, Comac Medical

Thomas Bols
Head of Government Affairs and Patient Advocacy, EMEA, PTC Therapeutics

Sara Bonetti
Senior Scientist, Salipro Biotech AB

Louis Boon
Chief Scientific Officer and Board Member, JJP Biologics

Tanima Bose
Senior Principal Scientist, Analytical Lead, Novartis

Laure Bouchez
Executive in Residence, General Inception

Frederic Bouder
Professor of Risk Management, University of Stavanger

Caroline Boulliat
MD, Genchrome

Jerome Boyd-Kirkup
Chief Scientific Officer, Hummingbird Bioscience

Diego Braguglia
GP, VI Partners

Julia Braunmüller
Manager Scientific & Technical Affairs, Patheon, Thermo Fisher Scientific

David Brockwell
Professor, University of Leeds

Patrick Brossard
Director Clinical Pharmacology, Sobi (Swedish Orphan Biovitrum)

Valentin Bruttel
CSO, Toleris

Sascha Oliver Buchner
Co-Founder and Partner, Forty51 Ventures AG

Craig Burton
Executive Director, Biosimilars Council

Ursula Busse
Head of Regulatory Affairs, Tigen Pharma SA

Stéphane Busso
Scientist I - Cell Line Development, Fresenius Kabi SwissBioSim

Erica Byerley
Global Senior Tech Transfer Engineer, ThermoFisher Scientific

Michela Castellani-Kleinschroth
Head of MS&T, SKAN AG

Prasun Chakraborty
Founder and Chief Executive Officer, Genevation LTD

Arindam Chakraborty
PhD, General Manager, Enzene Biosciences Ltd

Barry Chester
Director, Pfizer

Andre Choo
Deputy Executive Director, Bioprocessing Technology Institute

Mimi Choon-Quinones
Founder & Board Chairman, Partners for Patients NGO

Michael Chungyoun
Chemical & Biomolecular Engineering, Johns Hopkins University

Rodolfo Ciuffa
Bioinformatics Software Engineer, Alloy Therapeutics

Natalie Coan
Senior Director, Pinsent Masons

Sam Cooper
Co-Founder, Phenomic AI

Tom Cornell
Protein Engineering Senior Manager, Abzena

Carmen De Santo
Cruk New Investigator Fellow, Birmingham Centre for Railway Research and Education (UK & Dubai)

Roberto Di Niro
Associate Director, Project Services, Q² Solutions

Gundo Diedrich
Executive Director, MacroGenics

Nikolay Dobrev
Head of Biology, Epsilico

Patrick Doonan
Director of Antibody Engineering, Ailux

Meghan Drummond
Director, Regeneron Genetic Medicines, Head of Auditory Sciences, Regeneron

Joan D'souza
Consultant, Independent PV Expert

Stefan Dübel
Director, Technical University of Braunschweig

Stefan Duhr
NanoTemper

Lindy Durrant
Joint CEO and CSO, Scancell Ltd

Hilmar Ebersbach
Chief Scientific Officer, Immunos Therapeutics

Jack Elands
CEO, Adcytherix

Dominik Escher
Managing Partner, Pureos Bioventures

Thierry Escudier
Chairman, DCRIPT (Comac Medical Consultant)

Jennifer Eyerman
Clinical Trial Partner, Roche

Séverine Fagète
Vice President, Mammalian Cell Line Services, KBI Biopharma

David Falck
Assistant Professor, Leiden University Medical Center (Netherlands)

Mourad Farouk Rezk
Global Head of Medical and Development, Biosimilars, Biogen

Matthias Feige
Technical University Munich

Nadia Fernandez
Industry Clinical Collaboration Leader, F. Hoffmann-La Roche Ltd.

Maria Fiammetta Romano
Professor, University of Naples Federico II

Gregory Fiore
Former CEO, Exacis Biotherapeutics

Helena Maja Firczuk
Protein Expression Technologies Team Leader, GSK

Jens A Fischer
Program Manager (Large Molecule Research) for Immunology, Infectious Diseases & Rare Blood Disorders, Roche

Kevin Fitzgerald
Chief Scientific Officer, Epsilogen

Etienne, François, Léo Matous
Senior Principal Scientist and Head of Lead Optimization, Ichnos Glenmark Innovation

Linnea Franssen
Senior M&S Scientist, Roche

Margaux Fresnais
Mass Spectrometry Expert, University of Heidelberg

Andrea Galbiati
Group Leader, Chemistry, Philochem

Laura Garcia Prat
Scientist, Cimeio Therapeutics

Ettore Gilardoni
Head of Mass Spectrometry, Philochem

John Gill IV
Gilead Sciences

Adi Goldezweig
CTO, Scala Biodesign

Steffen Goletz
Professor, Department of Biotechnology and Biomedicine, Danish Technical University

Ridhima Gomkale
Platform Development Scientist, LenioBio

Heidi Wei Gong
CMC Operation General Manager, Aton Biotech

Dragan Grabulovski
Chief Executive Officer, ARARIS Biotech

Christoph Grapentin
Group Leader Formulation Development, Lonza Group Ltd

Torbjorn Graslund
Professor, K.T.H. Royal Institute of Technology

Ulf Grawunder
Chief Executive Officer & Co-Founder, T-Curx

Sherry Gu
EVP & CTO, WuXi Biologics

Uwe Gudat
Chief Medical Officer, Biocon Biologics

Stefano Gullà
CSO, Kling Biotherapeutics

Prateek Gupta
SVP and Head, Technical Development & MSAT, Stelis Biopharma

Thomas Hach
GPCH, Novartis

Livnat Halel
Experienced Clinical Projects Manager, Independent

Eric Halioua
President & Chief Executive Officer, PDC*line pharma SA

Anissa Harbi
Immunologist, Les Hôpitaux d'Alger

Emma Harding
Senior Director, Head of Molecular Design and Engineering, Large Molecule Discovery, GSK

Luluah Hashim Husain
Global Head of Finance, Biosimilars, Biogen

Barbara Hebeis
Senior Director, AstraZeneca

Hooman Hefzi
Associate Professor, Danish Technical University

Katrin Heinrich
Scientist, Roche Diagnostics GmbH

Charlie Heise
Associate Director, Bioprocessing Strategy & Development, FUJIFILM Diosynth Biotechnologies

Tim Heiseler
Senior Application Scientist, Sartorius

Ian Henshaw
Senior Principal Scientist, Amgen

Manish Khatri
Director, Clinical Science Data & AI Lead, Clinical Development, Novartis

Divor Kiseljak
Chief Operating Officer, ExcellGene

Christian Klein
Dept Head, Roche Pharmaceutical Research and Early Development

Isabel Kolinko
Digital Transformation and Data Analytics Manager, Genedata

Dmitrij Kollins
Clinical Development Medical Director, Novartis

Harald Kolmar
Head of Department Applied Biochemistry, TU Darmstadt Biochemie

Bertolt Kreft
CSO, Bright Peak Therapeutics AG

Peter Kristensen
Professor, Aalborg University

Dan Bach Kristensen
Scientific Director, Symphogen

Anil Kumar
Head of CMC, Europe, ACROBiosystems

David Laine
Director of Antibody Generation, Teva Pharmaceuticals

Vincent Larraillet
Senior Scientist, Roche

Mayra Latorre-Martinez
Clinical Study Assessor, Swissmedic

Heinz Läubli
Group Leader, Head of Clinical Research Oncology, University Hospital Basel

Amélie Laurendon
Principal Scientist, Ichnos Glenmark Innovation

Victor Le
Scientist, Novartis

Nicolas Lebesgue
Principal Scientist, Novartis Pharma AG

Gabrielle Leclercq
Senior Scientist, Roche Glycart

Steve Lehrer
MD, SBLehrer LLC

Justyna Leja-Jarblad
Head of Clinical Development, Lokon Pharma

Jimmy Li
CEO, WuXi XDC

Hong Liang
Professor, Shanghai Jiao Tong University

Giuseppe Licari
Lead Scientist Computational Structural Biology, Merck KGaA Darmstadt Germany

Lars Linden
Head Biologics Research, Bayer AG

Britta Lipinski
PhD Candidate, Antibody Discovery and Protein Engineering, Merck Healthcare KGaA

Pasquale Lombardi
Clinical Fellow, Imperial College London

Rémi Longuespée
Mass Spectrometry Expert, DKFZ

Robin Loving
CSO, Salipro Biotech AB

Maria Lteif
PhD student, Paris Saclay University

Luciano Lucas
Senior Director AI Product, Imaging Innovation, Leica Microsystems

Narendra Maharaj
Head, Clinical Development, Biologics, Dr Reddys Laboratories Limited

Bernard Maillere
Head of Laboratory, CEA

Magdalena Malm
Lab Manager, Research Scientist, Royal Institute of Technology

Martina Marauli
Director Clinical Supply Innovation, MSD Innovation & Development GmbH

Julie Maréchal-Jamil
Director Biosimilars Policy & Science, Medicines for Europe

Marisca Marian
Access Strategy Lead, Bayer

Andrea Marschall
Postdoctoral, Technical University of Braunschweig

Aimee Mattei
Director of Bioinformatics, EpiVax Inc

Alessandro Mazzetti
Head, Innovation and Entrepreneurship, Deputy Managing Director, University of Basel

John McCafferty
Founder and Chief Executive Officer, Maxion Therapeutics

Pamela McLaughlin
Clinical Trial Manager and Clinical Chemist, PhD, University Hospital Basel

Raj Mehta
CEO, Adendra Therapeutics

Clive Metcalfe
Principal Scientist Monoclonal Antibodies, MHRA

Salah M-Glueer
Co-Founder and Director of Research and Development, PeriCard Check GmbH

Erich Michel
Senior Researcher, University of Zurich

Cléa Michel
Product Management Director, Evonik

Enkelejda Miho
Dean and Professor, University of Applied Sciences Northwestern Switzerland

Dr. Michel Mikhail
Expert in Global Regulatory Affairs and Governmental Relations, Expert in Biosimilars, Independent

Lorenzo Montrasio
Member of Volrethics Steering Committee, Former Council of Europe

Gustavo Moreira
Head of Antibody and Protein Biochemistry, Tacalyx

Aurore Morello
Head of Research, Director of R&D, O.S.E. Immunotherapeutics

Lotte Mousset
Scientist, LAVA Therapeutics

Andre Mueller
Marketing Manager, Biologics Solutions, Unchained Labs

Michael Muenzberg
Business Development Officer, Rotterdam Biologics B.V.

Marius Müller
Team Lead Analytical Fill-Finish Support, Janssen

Dario Neri
Professor, ETH and CEO, Philogen

Sarfaraz Niazi
Professor, University of Illinois

Francesca Nice
Senior Scientist, Alchemab Therapeutics Ltd

Cecil Nick
Vice President (Technical), Parexel

Björn Niebel
Senior Principal Scientist, Sanofi Ghent - Sanofi R&D

Ahuva Nissim
Professor, Queen Mary University

Peter O'Callaghan
Senior Director, Licensing, Lonza Biologics

David O'Connell
Associate Professor, School of Biomolecular and Biomedical Science, University College Dublin

Sebastian Oehler
Senior Scientist, Philochem

Aline Oliveira
Competitive Intelligence Analyst, Institute of Technology on Immunobiologicals (Bio-Manguinhos)

Wayne Paes
Senior Scientist, Grey Wolf Therapeutics

Aniko Palfi
Director Biochemistry & Cell Biology, Heidelberg Pharma

Joseph PARK
Senior Manager, Samsung Bioepis

Samantha Paston
Head of Translational Research, Scancell Ltd

Romain Pastor
Associate Director, Novartis

Yash Patel
Product Specialist CLD, Sartorius

Thirupathi Pattipaka
Director, Advanced Analytics, Novartis

Lewis Penny
Principal Scientist (Fluid Biomarkers), Taurx Therapeutics Ltd

Mario Pereira
Director of Technology and Business Development, ATUM

Isabelle Petit-Topin
Team/Lab Lead in Downstream Process & Manufacturing Science and Technology (DSP MS and T), Novartis France

Douglas Phillips
Senior Scientist Antibody Discovery, Mabylon AG

Andreas Plueckthun
Professor of Biochemistry, Director, Department of Biochemistry, University of Zurich

Simon Plyte
CSO, Biomunex Pharmaceuticals

Philipp Probst
Director ADC Research, Araris Biotech AG

Léa Proulx
Patient Voice Partner, Roche

Steve Quayle
VP Research Biology & Translational Medicine, CUE Biopharma

Moutih Rafei
Full Professor, University of Montreal

Alexander Rau
Scientist Protein Engineering, Anaveon

Katharina Reefschläger
Technical Sales Specialist Custom Antibodies, Bio-Rad

Andreas Reimann
Principal Scientist, Ichnos Glenmark Innovation

Pramila Rijal
Career Development Fellow, University of Oxford

Tracey Roberts
Senior Associate, Pinsent Masons

Johan Rockberg
Professor, KTH

Natalia Rodrigues Mantuano
Project Leader, University Hospital of Basel

CHRISTINE ROTHE
Chief Development Officer, iOmx Therapeutics AG

Giulio Russo
Senior Scientist, Merus

Nicolas Sabarth
Research Laboratory Head in Biotherapeutics Discovery and Cancer Immunology, Boehringer Ingelheim

Anguraj Sadanandam
Team Leader, Institute of Cancer Research

Sreedhar Sagi
Head, Medical Affairs International Region, Sandoz

Ulisse Salazar
PhD Candidate, University of Zurich

Rainel Sanchez de la Rosa
Executive Director Medical Affairs Europe, Astellas Gene Therapy

Paul Sauter
Director Chemistry & Bioconjugation, Veraxa Biotech GmbH

Adrien Schmid
Senior Manager, CSL Behring AG

Simone Schmitt
VP Technology and Operations, Memo Therapeutics AG

Jan Schnitzer
CEO, P.R.I.S.M.

Fabian Schuette
Commercial Business Development Manager, Gerresheimer

Felix Schumacher
Program Leader, Targeted Therapeutics, Roche

El-houcine Sebbar
Professor MD PhD, Faculté de médecine et de pharmacie d'Oujda, Université Mohammed Premier d'Oujda

Monique Seymour
Senior Scientific Sales Executive, Rapid Novor Inc

Caibin Sheng
Senior Scientist, GV20 Therapeutics

Lei Shi
Senior Vice President, Biointron Biological

Elena Shvets
Group Leader, Sphere Fluidics

Oliver Siefert
Senior Scientist, University of Stuttgart

Tomasz Sitar
Head of CMC, JJP Biologics

Dr. Sun Chau Siu
Executive Director, Head of Global Regulatory Affairs, Altruist Biologics

Nathalie Steinhoff
Associate Director, Group Leader Pharm/Tox, Numab Therapeutics AG

Andreas Stengl
Team Lead, Protein Engineering, Ludwig Maximilians University Munich

Lars Stöckl
Division Manager, FyoniBio GmbH

Manhee Suh
CTO, Kactus

Mariam Sultani
Director, Global Supply Operations, Pfizer Seagen

Mats Sundgren
Senior Industry Scientific Director, i-hd The European Institute for Innovation through Health Data

Joseph Taft
Senior Scientist, Engimmune

Oya Tagit
Professor of Biointerfaces, University of Applied Sciences Northwestern Switzerland

Jian Tang
Associate Professor, H.E.C. Montreal

Cuong Tang
Scientific Business Analyst, Sapio Sciences

Lorenz Tanner
Member of Patient Board, SAKK Swiss Group for Clinical Cancer Research

Nazanin Tatari
Post-Doctoral Fellow, University Hospital Basel

Stefanos Theoharis
Chief Executive Officer, OneChain Immunotherapeutics

Michael Thiele
Founder and Chief Scientific Officer, OncoOne Research & Development GmbH

Bert Thomas
Senior Vice President Of Business Development, Bio-Thera Solutions

Laurent Thouvais
Sr Director, D&M BD, PCI Pharma Services

Jakub Tomala
Assistant Research Professor, John Hopkins University

Stephanie Traub
Associate Director, UCB

Marco Traub
Chief Executive Officer, TESCT - The Trans European Stem Cell Therapy Society

Gareth Tucker
Commercial Director, Impact Medical Education

Matthew Turner
Government affairs and Biosimilar Policy expert, Independent

Mikko Turunen
Chief Scientific Officer, RNatives

Jens Twellmeyer
Associate Director Science & Technology, Novartis AG

Laura Unmuth
PhD candidate - Early Protein Supply & Characterization, Merck KGaA

Feruza Ushurova
Clinical trial manager, SWISS GO Trial Group

Mart Ustav
CSO, Icosagen Therapeutics

Alain Vertes
Managing Director, NxR Biotechnologies GmbH

Pieter Voermans
Head Clinical Data Management, Sobi

Annette Vogl
VP, Biology and Translational Research, Tubulis GmbH

Ilona Vollrath
Senior Scientist, Roche

Angela Vollstedt
Global Director of Cell and Gene Therapies Portfolio Management, Novartis

Meenu Wadhwa
Section Head, MHRA

Koen Wagner
Senior Scientist for Antibody Engineering and Protein Chemistry, Merus

Theodora Weisz
Head of Patient Advocacy and Public Affairs, Novartis Gene Therapies

Ann White
Senior Director of Translational Science, Mestag Therapeutics

Jörg Wischhusen
Professor, Universitätsklinikum Würzburg

Uwe Wittenberg
Digital Data & IT Business Partner Pre-Clinical Research, Merck Healthcare KGaA, Darmstadt, Germany

Frederick Wittke
Vaccines Clinical Development Team Lead Europe, Independent

Gillian Woollett
VP, Head Regulatory Strategy and Policy, Samsung Bioepis

Rebecca Xicluna
Senior Scientist, F.Hoffmann-La Roche Ltd

Haoheng Sandy Yan
Head of US Regulatory Affairs, Shanghai Henlius Biotech Co., Ltd.

Desislava Yanakieva
Lab Head - Antibody Discovery and Engineering & Cell Assay Development, Merck KGaA

Che Yang
Specialist, Novo Nordisk

Voot Yin
Principal Scientist, The Jackson Laboratory

Yi-Ru Yu
Senior Scientist, Pilatus Biosciences SA

Michael Zaiac
Head of Medical Affairs Oncology Europe and Canada, Daiichi Sankyo

Jiyong Zhang
Head of Business Development, Nona Biosciences

Alla Zilberman
Vice President, Technical Marketing, Cygnus Technologies Inc

Iwan Zimmermann
Chief Operating Officer, Linkster Therapeutics AG

Michela Zuccolo
Gene Therapy and Rare Strategy, Roche

2024 Sponsors

PLATINUM SPONSORS:
• Fujifilm
• MabDesign
• Lonza

DIAMOND SPONSORS:
• Nona Biosciences
• Genedata
• XDC

GOLD SPONSORS:
• Ailux
• ATUM
• Altruist
• Croda
• Enzene
• Icosagen
• Refeyn

SILVER SPONSORS:
• Abzena
• ACRO Biosystems
• Alloy Therapeutics
• Ardigen
• Bio-Rad
• Bio-techne
• Cygnus Technologies
• Evonik
• Genovac
• Celonic
• Cytiva
• ExcellGene
• ProBio
• Harro Hofliger
• Kactus
• Molecular Devices
• OmniAb
• Immunoprecise Antibodies
• Lightcast Discovery
• NanoTemper
• Q2 Solutions
• Sapio Sciences
• Selvita
• Shilpa Biologicals
• Stelis Biopharma
• Schrodinger
• SGS
• Sphere Fluidics
• Thermo Fisher Scientific
• Twist
• Veraxa

BRONZE SPONSORS:
• Absci
• Aton Biotech
• FyoniBio
• Impact Medical Education
• LenioBio
• Agilent Technologies
• Carterra
• Gerresheimer
• KBI Biopharma
• Luminex
• PCI Pharma Services
• Pfizer
• PipeBio
• Seromyx Systems
• PeriCard
• Pinsent Masons LLP
• Rapid Novor
• Unchained Labs
• WuXi Biologics